Ward Robert 4
4 · Eloxx Pharmaceuticals, Inc. · Filed Sep 27, 2019
Insider Transaction Report
Form 4
Ward Robert
DirectorChief Executive Officer
Transactions
- Tax Payment
Common Stock
2019-09-26$4.37/sh−10,467$45,741→ 170,953 total - Exercise/Conversion
Common Stock
2019-09-26+35,599→ 181,420 total - Exercise/Conversion
Restricted Stock Units
2019-09-26−35,599→ 320,393 total→ Common Stock (35,599 underlying)
Footnotes (6)
- [F1]The restricted stock units issued to the reporting person on December 26, 2017 have partially vested and settled for shares of the Issuer's common stock.
- [F2]Of this amount, 166,420 shares are held by the Robert E. Ward 2017 Revocable Trust of which Mr. Ward is a trustee.
- [F3]Of this amount, 155,953 shares are held by the Robert E. Ward 2017 Revocable Trust of which Mr. Ward is a trustee.
- [F4]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F5]The restricted stock units were issued pursuant to the Issuer's 2013 Share Ownership and Option Plan.
- [F6]The remaining restricted stock units will vest ratably each quarter through December 26, 2021 subject to the reporting person's continued employment with the Issuer, which vesting may be accelerated in certain circumstances.